NCT03416543View on ClinicalTrials.gov

Effect of a New BI-specifiC Antibody Towards Dendritic Cells on Inflammation in Rheumatoid Arthritis

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

December 13, 2017

Primary Completion Date

December 8, 2021

Study Completion Date

December 8, 2021

Conditions
Rheumatoid ArthritisGoutOsteoarthritis
Interventions
OTHER

Puncture

Puncture necessary for daily practice in patients with acute arthritis of RA or Gout or osteoarthritis

Trial Locations (1)

37044

Rheumatology Department, University Hospital, Tours, Tours

All Listed Sponsors
lead

University Hospital, Tours

OTHER

NCT03416543 - Effect of a New BI-specifiC Antibody Towards Dendritic Cells on Inflammation in Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter